Thoracic endovascular aortic repair (TEVAR) has transformed the management of type B aortic dissection (TBAD), yet its biological consequences remain substantially less understood than its mechanical effects. Stent-graft implantation occurs within an already injured and immunologically active aorta, creating a new interface between circulating blood, biomaterial, thrombus, endothelium, and the dissected aortic wall. This review examines the immune, thrombotic, cellular, and extracellular matrix responses associated with TEVAR and proposes a framework linking these processes to false-lumen healing and aortic remodeling. Evidence from clinical, translational, biomaterial, imaging, and experimental studies was critically integrated to examine pre-existing inflammatory activity in TBAD; blood–stent-graft interactions; complement, platelet, neutrophil, and monocyte/macrophage responses; post-implantation syndrome; false-lumen thrombosis and organization; endothelial and extracellular-matrix remodeling; and emerging approaches to longitudinal immune phenotyping. Available evidence supports a model in which post-TEVAR inflammation represents a composite response arising from pre-existing dissection biology, procedural injury, biomaterial exposure, altered mechanobiology, and therapeutically induced thrombosis rather than an isolated device reaction. Early immunothrombotic activation may contribute to false-lumen thrombosis and subsequent organization, whereas persistent immune activation, proteolysis, residual perfusion, and failure of inflammatory resolution may accompany adverse remodeling. Conventional markers such as fever, leukocytosis, C-reactive protein, and post-implantation syndrome provide limited mechanistic resolution. Integration of serial cellular and molecular phenotyping with quantitative imaging may better distinguish adaptive healing from persistent thrombo-inflammatory activity. TEVAR should be understood as both a mechanical intervention and a biological perturbation. The clinically relevant objective is not simply to quantify postoperative inflammation, but to define its origin, cellular composition, temporal evolution, and relationship to false-lumen organization and structural remodeling. Prospective longitudinal studies integrating immune phenotyping, device characteristics, quantitative imaging, and selected proteomic, single-cell, and spatial approaches are needed before immune signatures can guide prognosis or therapeutic intervention.
Krasiński, Z., Kowalewski, M., Urbanowicz, T., Pisano, C., Nuzzi, V., Suwalski, P., et al. (2026). Beyond Mechanical Exclusion: Immune and Cellular Remodeling After Stent-Graft Implantation in Type B Aortic Dissection. BIOMEDICINES, 14(11) [10.3390/biomedicines14112642].
Beyond Mechanical Exclusion: Immune and Cellular Remodeling After Stent-Graft Implantation in Type B Aortic Dissection
Pisano, Calogera;Raffa, Giuseppe MariaUltimo
2026-11-16
Abstract
Thoracic endovascular aortic repair (TEVAR) has transformed the management of type B aortic dissection (TBAD), yet its biological consequences remain substantially less understood than its mechanical effects. Stent-graft implantation occurs within an already injured and immunologically active aorta, creating a new interface between circulating blood, biomaterial, thrombus, endothelium, and the dissected aortic wall. This review examines the immune, thrombotic, cellular, and extracellular matrix responses associated with TEVAR and proposes a framework linking these processes to false-lumen healing and aortic remodeling. Evidence from clinical, translational, biomaterial, imaging, and experimental studies was critically integrated to examine pre-existing inflammatory activity in TBAD; blood–stent-graft interactions; complement, platelet, neutrophil, and monocyte/macrophage responses; post-implantation syndrome; false-lumen thrombosis and organization; endothelial and extracellular-matrix remodeling; and emerging approaches to longitudinal immune phenotyping. Available evidence supports a model in which post-TEVAR inflammation represents a composite response arising from pre-existing dissection biology, procedural injury, biomaterial exposure, altered mechanobiology, and therapeutically induced thrombosis rather than an isolated device reaction. Early immunothrombotic activation may contribute to false-lumen thrombosis and subsequent organization, whereas persistent immune activation, proteolysis, residual perfusion, and failure of inflammatory resolution may accompany adverse remodeling. Conventional markers such as fever, leukocytosis, C-reactive protein, and post-implantation syndrome provide limited mechanistic resolution. Integration of serial cellular and molecular phenotyping with quantitative imaging may better distinguish adaptive healing from persistent thrombo-inflammatory activity. TEVAR should be understood as both a mechanical intervention and a biological perturbation. The clinically relevant objective is not simply to quantify postoperative inflammation, but to define its origin, cellular composition, temporal evolution, and relationship to false-lumen organization and structural remodeling. Prospective longitudinal studies integrating immune phenotyping, device characteristics, quantitative imaging, and selected proteomic, single-cell, and spatial approaches are needed before immune signatures can guide prognosis or therapeutic intervention.| File | Dimensione | Formato | |
|---|---|---|---|
|
biomedicines-14-02642.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
16.83 MB
Formato
Adobe PDF
|
16.83 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


